Treatment of Dysmenorrhea with Physiological Modulators (A28): A Registry Study| Stephy Publishers
Pregnancy and Women’s Health Care International Journal - (PWHCIJ)| Stephy Publishers
Abstract
Background: Dysmenorrhea is a diseases affecting
about 45% of menstruating women (approximately between 45 to 95 % of females)
during the time of menses and causing a reduction of the quality of life.
Objectives: To reduce the symptoms of dysmenorrhea
using a natural Physiological Mosdulator (A 28) consisting of low dosages of
calcium salts, Vitamin D, bioflavonoids, lycopene, and astaxanthin.
Material and methods: Forty patients with severe dysmenorrhea
were analyzed during two menstrual cycles: the first as baseline following a
run-inn period, and the second during the treatment with A28. A simple VAS
scale scoring the daily discomfort (from 0 =no discomfort to 6 =maximum
discomfort) was used to measure the severity of the symptoms.The total score of
first 3 days following the start of menses was calculated.The use of pain
rescue cps during the two period was compared.
Results: Thirty-eight cases completed the
experience. Before treatment, the mean of total scores was 8.1±2.40, while
after A28 it was reduced to 1.7± 1.39 (U Mann Whitney p< 0.01) . The mean of
pain rescue cps used was respectively 6.1±1.21 and 0.5±1.15 before and after
the A28 treatment (p <0.01). No side effects were reported.
Conclusion: The use ofa combination of Physiological
Modulators effectively decreased the daily discomfort due to dysmenorrhea.
Keywords
dysmenorrhea,
physiological modulators, daily discomfort
Introduction
Dysmenorrhea is a
diseases affecting about 45 % of menstruating women (approximately between 45
to 95 % of females) during the time of menses,1 causing an extensive personal and public health problem
consisting of a high degree of absenteeism and severe economic loss. Recently
some author has focused the attention on GABA and CaSRs (calcium sensing
receptors): the GABA receptors are spread into the CNS and GI tract with
inhibitory activity,2,3 while CaSRS are more expressed into the
GI.4 The GABA receptors have an inhibitory
activity which is modulated by estrogens and progestins, and their reduction
allows the start of menses. At the same time, the hormonal shortage give rise
to pain and GI hypermotility, the last being controlled by the CaSRs inhibitory
activity. It may be interesting consider that receptors of any type (e.g. for
serotonin, norepinephrine, GABA) are located primarily on the cellular
membranes. The membrane functions in general belong to the oxidative condition
of the membrane itself, and the receptor is maintained in place with the normal
function depending upon the membrane structure around and within the receptor.
The membrane around and within the receptor (rafts) can have a differential
sensitivity to the oxidative stress (OS) depending upon the quantity of double
bonds in the lipids constituting the phospholipids (PL) and the antioxidant
reserve available in the cellular system.5 Lipids rafts,
consisting of cholesterol/sfingolipids microdomains are involved in protein
traffic, formation of signaling complexes and are abundantly represented in
several postsynaptic dendrites.6 This means that
a neuroamine receptor (e.g. for serotonin, dopamine) may be more sensible to
the oxidation than an estrogenic receptor or vice versa. The consequence of
this is that even a mild oxidation in absence of an adequate antioxidant
capacity can trigger the dysfunction of some receptors only, whereas a massive
oxidation generate a complete dysregulation of all the receptors. In any case,
the oxidative stress tends to be an explosive process, and even a mild
oxidation starting in one point/area of the cellular membrane may be spread out
rapidly involving all the proximal areas. This means that is possible to stop
the explosive process just limiting the membrane oxidation, and the relative
clinical symptoms will not emerge. These last aspects make clear that OS may
compromise directly (receptor per se) or indirectly (rafts oxidation) the
neuronal firing, and inhibitory neurons can be more sensible than stimulating
neurons, due the higher number of cysteine loops. The aim of this investigation
was to analyze the activity of a Physiological Modulators Formula (A28) to
control the daily discomfort due to dysmenorrhea symptoms. A28 is a combination
of citrus flavonoids to control oxidative stress (OS), calcium salts to
modulate pain an motility in the gut, Vitamin D to increase intestinal the
calcium availability7, astaxanthin to reduce the OS in the brain,8 and lycopene to quench the oxidation in lymphocytes.
To read more #Pregnancy #WomensHealth
https://www.stephypublishers.com/pwhcij/fulltext/PWHCIJ.MS.ID.000501.php
#Openaccessjournals
https://www.stephypublishers.com/
Comments
Post a Comment